Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio-Medico

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)	Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, skin disorder, systemic sclerosis	Not yet recruiting	Not stated	2026-06-11		NCT07642297
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.	Psoriasis Arthritis	Recruiting	Phase 4	2025-05-16		NCT06974474

Clinical trials